The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety results from a phase III trial of nivolumab (NIVO) alone or combined with ipilimumab (IPI) versus IPI alone in treatment-naive patients (pts) with advanced melanoma (MEL) (CheckMate 067).
 
Jedd D. Wolchok
Stock and Other Ownership Interests - Potenza Therapeutics; Vesuvius Pharmaceuticals
Honoraria - EMD Serono; Janssen Oncology
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; Jounce Therapeutics; MedImmune; Merck; Polaris; Polynoma; ZIOPHARM Oncology
Research Funding - Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); MedImmune (Inst); Merck (Inst)
Patents, Royalties, Other Intellectual Property - I am a co-inventor on an issued patent for DNA vaccines for treatment of cancer in companion animals.
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Vanna Chiarion-Sileni
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; MSD; Roche Pharma AG
Speakers' Bureau - Bristol-Myers Squibb; GlaxoSmithKline; Roche Pharma AG
Travel, Accommodations, Expenses - Bristol-Myers Squibb; GlaxoSmithKline; MSD; Roche Pharma AG
 
Rene Gonzalez
Honoraria - Amgen; Bristol-Myers Squibb; Castle Biosciences; GlaxoSmithKline; Roche/Genentech
Consulting or Advisory Role - Piramal Life Science; Roche Pharma AG
Research Funding - Bristol-Myers Squibb (Inst); Castle Biosciences (Inst); GlaxoSmithKline (Inst); Merck (Inst); Roche/Genentech (Inst)
 
Piotr Rutkowski
Honoraria - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; MSD; Novartis; Pfizer; Roche Pharma AG
Consulting or Advisory Role - Bristol-Myers Squibb; MSD; Novartis
Speakers' Bureau - Bristol-Myers Squibb; MSD; Pfizer
Research Funding - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Novartis
 
Jean Jacques Grob
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Merck; Novartis; Roche Pharma AG
Speakers' Bureau - Bristol-Myers Squibb; GlaxoSmithKline; Roche Pharma AG
Research Funding - Bristol-Myers Squibb; Roche Pharma AG
Travel, Accommodations, Expenses - Roche Pharma AG
 
Charles Lance Cowey
Employment - Texas Oncology
Leadership - US Oncology
Stock and Other Ownership Interests - Texas Oncology
Honoraria - Bristol-Myers Squibb; Castle Biosciences; Celgene; Merck; Novartis
Consulting or Advisory Role - Castle Biosciences; Celgene; Novartis
Speakers' Bureau - Bristol-Myers Squibb; Merck
Research Funding - Bristol-Myers Squibb; EMD Serono; Genentech; Merck; Roche Pharma AG
 
Christopher D. Lao
No Relationships to Disclose
 
Dirk Schadendorf
Honoraria - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; MSD; Novartis; Roche Pharma AG
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; MSD; Novartis; Roche Pharma AG
Speakers' Bureau - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; MSD; Novartis; Roche Pharma AG
Research Funding - MSD (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; MSD; Novartis; Roche Pharma AG
 
Pier Francesco Ferrucci
Honoraria - Delcath Systems
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; Roche Pharma AG
Expert Testimony - Bristol-Myers Squibb; GlaxoSmithKline; Roche Pharma AG
Travel, Accommodations, Expenses - Bristol-Myers Squibb; GlaxoSmithKline; Roche Pharma AG
 
Michael Smylie
Honoraria - Bristol-Myers Squibb; GlaxoSmithKline; Merck; Roche Pharma AG
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; Merck; Roche Pharma AG
Speakers' Bureau - Bristol-Myers Squibb; Roche Pharma AG
 
Reinhard Dummer
Honoraria - Bristol-Myers Squibb; GlaxoSmithKline; MSD; Novartis; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; MSD; Novartis; Roche
Research Funding - Bristol-Myers Squibb; GlaxoSmithKline; MSD; Novartis; Roche
 
Andrew Graham Hill
Employment - Tasman Oncology; Tasman Oncology
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
John B. A. G. Haanen
Consulting or Advisory Role - MSD; Pfizer; Roche Pharma AG
Research Funding - Bristol-Myers Squibb; GlaxoSmithKline
 
Michele Maio
Honoraria - Bristol-Myers Squibb; GlaxoSmithKline; MedImmune; MSD; Roche Pharma AG
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; MedImmune; MSD; Roche Pharma AG
Research Funding - Bristol-Myers Squibb; MedImmune
Travel, Accommodations, Expenses - Bristol-Myers Squibb; GlaxoSmithKline; MedImmune; MSD; Roche Pharma AG
 
Grant A. McArthur
Consulting or Advisory Role - Provectus
Research Funding - Celgene; Novartis; Pfizer; Ventana Medical Systems
Travel, Accommodations, Expenses - Merck; Roche Pharma AG
 
Arvin Yang
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Linda Rollin
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Christine E. Horak
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
James M. G. Larkin
Research Funding - Novartis (Inst); Pfizer (Inst)
 
F. Stephen Hodi
Consulting or Advisory Role - Merck Sharp & Dohme; Novartis
Research Funding - bristol-myers squibb (Inst); Genentech/Roche (Inst); Merck Sharp & Dohme (Inst); novartis (Inst)
Patents, Royalties, Other Intellectual Property - patent pending as per institutional policy (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis
Other Relationship - Bristol-Myers Squibb; Genentech/Roche